Ulcerative colitis drug (Novome Biotechnologies)

N/A

Report date: 2025/01/26 16:16:16

Base Information

Drug NameUlcerative colitis drug (Novome Biotechnologies)
Drug Alias NameUlcerative colitis (Novome Biotechnologies)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovome Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovome Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A